Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Publication Information:
      BMC, 2020.
    • Publication Date:
      2020
    • Collection:
      LCC:Diseases of the circulatory (Cardiovascular) system
    • Abstract:
      Abstract Background Using cardiovascular magnetic resonance imaging (CMR), it is possible to detect diffuse fibrosis of the left ventricle (LV) in patients with atrial fibrillation (AF), which may be independently associated with recurrence of AF after ablation. By conducting CMR, clinical, electrophysiology and biomarker assessment we planned to investigate LV myocardial fibrosis in patients undergoing AF ablation. Methods LV fibrosis was assessed by T1 mapping in 31 patients undergoing percutaneous ablation for AF. Galectin-3, coronary sinus type I collagen C terminal telopeptide (ICTP), and type III procollagen N terminal peptide were measured with ELISA. Comparison was made between groups above and below the median for LV extracellular volume fraction (ECV), followed by regression analysis. Results On linear regression analysis LV ECV had significant associations with invasive left atrial pressure (Beta 0.49, P = 0.008) and coronary sinus ICTP (Beta 0.75, P
    • File Description:
      electronic resource
    • ISSN:
      1532-429X
    • Relation:
      http://link.springer.com/article/10.1186/s12968-020-0603-y; https://doaj.org/toc/1532-429X
    • Accession Number:
      10.1186/s12968-020-0603-y
    • Rights:
      Journal Licence: CC BY
    • Accession Number:
      edsdoj.94383803568d48a1989191f0a0e34cf3
  • Citations
    • ABNT:
      GORDON A. BEGG et al. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. Journal of Cardiovascular Magnetic Resonance, [s. l.], v. 22, n. 1, p. 1–7, 2020. DOI 10.1186/s12968-020-0603-y. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.94383803568d48a1989191f0a0e34cf3&custid=s8280428. Acesso em: 9 jul. 2020.
    • AMA:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, et al. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. Journal of Cardiovascular Magnetic Resonance. 2020;22(1):1-7. doi:10.1186/s12968-020-0603-y.
    • AMA11:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, et al. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. Journal of Cardiovascular Magnetic Resonance. 2020;22(1):1-7. doi:10.1186/s12968-020-0603-y
    • APA:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, Tobias Oesterlein, Kawal Rhode, Arun V. Holden, John P. Greenwood, Eduard Shantsila, Gregory Y. H. Lip, Sven Plein, & Muzahir H. Tayebjee. (2020). Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. Journal of Cardiovascular Magnetic Resonance, 22(1), 1–7. https://doi.org/10.1186/s12968-020-0603-y
    • Chicago/Turabian: Author-Date:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, Tobias Oesterlein, Kawal Rhode, Arun V. Holden, John P. Greenwood, et al. 2020. “Imaging, Biomarker and Invasive Assessment of Diffuse Left Ventricular Myocardial Fibrosis in Atrial Fibrillation.” Journal of Cardiovascular Magnetic Resonance 22 (1): 1–7. doi:10.1186/s12968-020-0603-y.
    • Harvard:
      Gordon A. Begg et al. (2020) ‘Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation’, Journal of Cardiovascular Magnetic Resonance, 22(1), pp. 1–7. doi: 10.1186/s12968-020-0603-y.
    • Harvard: Australian:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, Tobias Oesterlein, Kawal Rhode, Arun V. Holden, John P. Greenwood, Eduard Shantsila, Gregory Y. H. Lip, Sven Plein & Muzahir H. Tayebjee 2020, ‘Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation’, Journal of Cardiovascular Magnetic Resonance, vol. 22, no. 1, pp. 1–7, viewed 9 July 2020, .
    • MLA:
      Gordon A. Begg, et al. “Imaging, Biomarker and Invasive Assessment of Diffuse Left Ventricular Myocardial Fibrosis in Atrial Fibrillation.” Journal of Cardiovascular Magnetic Resonance, vol. 22, no. 1, Feb. 2020, pp. 1–7. EBSCOhost, doi:10.1186/s12968-020-0603-y.
    • Chicago/Turabian: Humanities:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, Tobias Oesterlein, Kawal Rhode, Arun V. Holden, John P. Greenwood, et al. “Imaging, Biomarker and Invasive Assessment of Diffuse Left Ventricular Myocardial Fibrosis in Atrial Fibrillation.” Journal of Cardiovascular Magnetic Resonance 22, no. 1 (February 1, 2020): 1–7. doi:10.1186/s12968-020-0603-y.
    • Vancouver/ICMJE:
      Gordon A. Begg, Peter P. Swoboda, Rashed Karim, Tobias Oesterlein, Kawal Rhode, Arun V. Holden, et al. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. Journal of Cardiovascular Magnetic Resonance [Internet]. 2020 Feb 1 [cited 2020 Jul 9];22(1):1–7. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsdoj&AN=edsdoj.94383803568d48a1989191f0a0e34cf3&custid=s8280428